Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 15, 2011 - Issue 7
Submit an article Journal homepage
256
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy

Servane Tauszig-DelamasureApoptosis, Cancer and Development Laboratory- Equipe labellisée ‘La Ligue’, Centre de Cancérologie de Lyon, INSERM U1052, CNRS UMR5238, Université de Lyon, Centre Léon Bérard, 69008 Lyon, France+33 4 78 78 28 87; [email protected]
&
Jimena Bouzas-RodriguezApoptosis, Cancer and Development Laboratory- Equipe labellisée ‘La Ligue’, Centre de Cancérologie de Lyon, INSERM U1052, CNRS UMR5238, Université de Lyon, Centre Léon Bérard, 69008 Lyon, France+33 4 78 78 28 87; [email protected]
Pages 847-858 | Published online: 08 Apr 2011

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Cristina E Tognon & Poul HB Sorensen. (2012) Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opinion on Therapeutic Targets 16:1, pages 33-48.
Read now

Articles from other publishers (11)

Yali Wei, Ping Lyu, Ruiye Bi, Xinyu Chen, Yanshen Yu, Zucen Li & Yi Fan. (2022) Neural Regeneration in Regenerative Endodontic Treatment: An Overview and Current Trends. International Journal of Molecular Sciences 23:24, pages 15492.
Crossref
Xin Cui, Jia Jing, Rui Wu, Qiang Cao, Fenfen Li, Ke Li, Shirong Wang, Liqing Yu, Gary Schwartz, Huidong Shi, Bingzhong Xue & Hang Shi. (2021) Adipose tissue-derived neurotrophic factor 3 regulates sympathetic innervation and thermogenesis in adipose tissue. Nature Communications 12:1.
Crossref
Marie Ménard, Clélia Costechareyre, Gabriel Ichim, Jonathan Blachier, David Neves, Loraine Jarrosson-Wuilleme, Reinhard Depping, Jan Koster, Pierre Saintigny, Patrick Mehlen & Servane Tauszig-Delamasure. (2018) Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth. PLOS Biology 16:5, pages e2002912.
Crossref
Subrata Pramanik, Yanuar Alan Sulistio & Klaus Heese. (2016) Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy. Molecular Neurobiology 54:9, pages 7401-7459.
Crossref
Xing Li, Yuan Zhang, Yaping Yan, Bogoljub Ciric, Cun-Gen Ma, Bruno Gran, Mark Curtis, Abdolmohamad Rostami & Guang-Xian Zhang. (2016) Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity. Molecular Therapy 24:8, pages 1456-1469.
Crossref
Wen-Ming PengLaura MaintzJean-Pierre AllamUlrike RaapInes GütgemannJutta KirfelEva Wardelmann, Sven PernerWei ZhaoRolf FimmersKlaus Walgenbach, Johannes OldenburgLawrence B. Schwartz & Natalija Novak. (2013) Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis. Blood 122:10, pages 1779-1788.
Crossref
S V Ivanov, A Panaccione, B Brown, Y Guo, C A Moskaluk, M J Wick, J L Brown, A V Ivanova, N Issaeva, A K El-Naggar & W G Yarbrough. (2012) TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene 32:32, pages 3698-3710.
Crossref
A.A. Philchenkov. (2013) Apoptosis-reactivating agents for targeted anticancer therapy. Biomeditsinskaya Khimiya 59:2, pages 119-143.
Crossref
Hubert Hondermarck. (2012) Neurotrophins and their receptors in breast cancer. Cytokine & Growth Factor Reviews 23:6, pages 357-365.
Crossref
A. A. Philchenkov. (2012) Apoptosis-reactivating agents for targeted anticancer therapy. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 6:4, pages 343-358.
Crossref
Dyan Ramekers, Huib Versnel, Wilko Grolman & Sjaak F.L. Klis. (2012) Neurotrophins and their role in the cochlea. Hearing Research 288:1-2, pages 19-33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.